Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HSTM Stock Forecast 2026-2027
$25.87
Current Price
$755.80M
Market Cap
Buy 2
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to HSTM Price Targets
+54.6%
To High Target of $40.00
+23.7%
To Median Target of $32.00
-7.2%
To Low Target of $24.00
HSTM Price Momentum
-0.5%
1 Week Change
+14.0%
1 Month Change
-6.0%
1 Year Change
+12.1%
Year-to-Date Change
-12.7%
From 52W High of $29.63
+32.7%
From 52W Low of $19.50
📊 TOP ANALYST CALLS
Did HSTM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if HealthStream is one of their latest high-conviction picks.
Latest HSTM Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, HSTM has a neutral consensus with a median price target of $32.00 (ranging from $24.00 to $40.00). The overall analyst rating is Buy (7.6/10). Currently trading at $25.87, the median forecast implies a 23.7% upside. This outlook is supported by 2 Buy, 3 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Close at Canaccord Genuity, suggesting a 7.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HSTM Analyst Ratings
2
Buy
3
Hold
0
Sell
HSTM Price Target Range
Low
$24.00
Average
$32.00
High
$40.00
Current: $25.87
Latest HSTM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HSTM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 6, 2026 | Canaccord Genuity | Richard Close | Hold | Maintains | $24.00 |
| Dec 17, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Aug 7, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| May 15, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Feb 26, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Feb 6, 2025 | JMP Securities | Market Perform | Reiterates | $N/A | |
| Oct 23, 2024 | Barclays | Overweight | Maintains | $N/A | |
| Oct 23, 2024 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Jul 24, 2024 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Dec 6, 2023 | JMP Securities | Market Perform | Initiates | $N/A | |
| Feb 22, 2023 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Apr 28, 2021 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Oct 28, 2020 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Dec 20, 2019 | Raymond James | Market Perform | Initiates | $N/A | |
| Jul 11, 2018 | Barrington Research | Market Perform | Downgrade | $N/A | |
| Jun 14, 2018 | Baird | Neutral | Downgrade | $N/A | |
| Oct 25, 2017 | Baird | Outperform | Maintains | $N/A | |
| Oct 25, 2017 | Needham | Hold | Downgrade | $N/A | |
| Jul 26, 2017 | First Analysis | Equal-Weight | Upgrade | $N/A | |
| Jan 23, 2017 | First Analysis | Underweight | Downgrade | $N/A |
HealthStream Inc. (HSTM) Competitors
The following stocks are similar to HealthStream based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HSTM
HealthStream
mkt cap
763.39M
HealthStream Inc. (HSTM) Financial Data
HealthStream Inc. has a market capitalization of $755.80M with a P/E ratio of 39.0x. The company generates $311.78M in trailing twelve-month revenue with a 6.4% profit margin.
Revenue growth is +10.5% quarter-over-quarter, while maintaining an operating margin of +9.3% and return on equity of +5.6%.
Valuation Metrics
Market Cap
$755.80M
Enterprise Value
$710.96M
P/E Ratio
39.0x
PEG Ratio
0.9x
Price/Sales
2.4x
Growth & Margins
Revenue Growth (YoY)
+10.5%
Gross Margin
+65.8%
Operating Margin
+9.3%
Net Margin
+6.4%
EPS Growth
+36.4%
Financial Health
Cash/Price Ratio
+8.8%
Current Ratio
1.0x
Debt/Equity
4.0x
ROE
+5.6%
ROA
+2.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
HealthStream Inc. (HSTM) Business Model
About HealthStream Inc.
What They Do
Provides workforce solutions for the healthcare industry.
Business Model
HealthStream generates revenue by offering cloud-based workforce and provider solutions, including learning platforms, credentialing services, and management tools tailored to healthcare professionals. By enhancing training and compliance, the company serves hospitals, healthcare systems, and educational institutions effectively.
Additional Information
HealthStream is dedicated to improving patient outcomes and operational efficiency while ensuring staff competence. Its niche focus on the healthcare sector positions it well to address the challenges of regulatory compliance in a dynamic environment.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
1,139
CEO
Mr. Robert A. Frist Jr.
Country
United States
IPO Year
2000
Website
www.healthstream.comHealthStream Inc. (HSTM) Latest News & Analysis
Latest News
Quick Summary
HealthStream (HSTM) and Sify Technologies Limited (SIFY) are two stocks in the Internet - Services sector that may interest value investors.
Why It Matters
The comparison between HealthStream and Sify Technologies highlights potential investment opportunities in the Internet - Services sector, influencing stock selection for value-focused investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
HealthStream (HSTM) and Sify Technologies Limited (SIFY) are notable stocks in the Internet - Services sector, attracting interest from value investors.
Why It Matters
Comparing HealthStream and Sify Technologies helps investors identify potential value opportunities in the Internet - Services sector, influencing stock selection and investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
HealthStream, Inc. (HSTM) held its Q1 2026 earnings call, discussing financial performance and operational updates. Further details can be found in the full transcript.
Why It Matters
The Q1 2026 earnings call for HealthStream, Inc. provides insights into financial performance, growth potential, and market position, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
HealthStream, Inc. reported Q1 2026 revenues of $81.2 million, a 10.5% increase from $73.5 million in Q1 2025. Operating income rose 71.6% to $7.5 million, with net income also reported.
Why It Matters
HealthStream's strong revenue growth and significant increase in operating income signal operational efficiency and potential for future profitability, attracting interest from growth-focused investors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
HealthStream (HSTM) reported Q3 earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.16 and up from $0.14 per share in the same quarter last year.
Why It Matters
HealthStream's earnings beat expectations, indicating stronger performance and growth year-over-year, which can boost investor confidence and affect stock prices positively.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
HealthStream, Inc. (Nasdaq: HSTM) will release Q1 2026 financial results on May 4, 2026, and host a conference call on May 5, 2026, to discuss the results.
Why It Matters
HealthStream's upcoming financial results can impact stock performance, influencing investor sentiment based on revenue, growth metrics, and market positioning in the healthcare tech sector.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About HSTM Stock
What is HealthStream Inc.'s (HSTM) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, HealthStream Inc. (HSTM) has a median price target of $32.00. The highest price target is $40.00 and the lowest is $24.00.
Is HSTM stock a good investment in 2026?
According to current analyst ratings, HSTM has 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $25.87. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HSTM stock?
Wall Street analysts predict HSTM stock could reach $32.00 in the next 12 months. This represents a 23.7% increase from the current price of $25.87. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is HealthStream Inc.'s business model?
HealthStream generates revenue by offering cloud-based workforce and provider solutions, including learning platforms, credentialing services, and management tools tailored to healthcare professionals. By enhancing training and compliance, the company serves hospitals, healthcare systems, and educational institutions effectively.
What is the highest forecasted price for HSTM HealthStream Inc.?
The highest price target for HSTM is $40.00 from at , which represents a 54.6% increase from the current price of $25.87.
What is the lowest forecasted price for HSTM HealthStream Inc.?
The lowest price target for HSTM is $24.00 from Richard Close at Canaccord Genuity, which represents a -7.2% decrease from the current price of $25.87.
What is the overall HSTM consensus from analysts for HealthStream Inc.?
The overall analyst consensus for HSTM is neutral. Out of 2 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $32.00.
How accurate are HSTM stock price projections?
Stock price projections, including those for HealthStream Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 7:37 AM UTC